pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
ARB-1002
Pancreatic Cancer
Arbele Ltd
0
catalysts
Phase 2
ARD-103
Refractory Acute Myeloid Leukemia
ARCE Therapeutics Inc
0
catalysts
Preclinical
ARR-002
Endometrial Cancer
Aarvik Therapeutics Inc
0
catalysts
Phase 1
ART-101
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
← prev
page 10 of 62
next →
131
Pain
89
Neurology
1
Archeus Technologies Inc
0
catalysts
Phase 1
ART-26.12
Chemotherapy Induced Peripheral Neuropathy
$ARTL
ARTELO BIOSCIENCES, INC.
0
catalysts
Phase 1
ART-4215
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Artios Pharma Ltd
0
catalysts
Phase 2
ART-6043
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Artios Pharma Ltd
0
catalysts
Phase 2
ARTS-021
Endometrial Cancer
Avenzo Therapeutics Inc
0
catalysts
Phase 2
ARTS-023
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Avenzo Therapeutics Inc
0
catalysts
Phase 2
ARV-806
Colorectal Cancer
$ARVN
ARVINAS, INC.
0
catalysts
Phase 1
ARX-305
Renal Cell Carcinoma
Ambrx Biopharma Inc
0
catalysts
Phase 1
ARX-517
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ambrx Biopharma Inc
0
catalysts
Preclinical
AS-00491
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
0
catalysts
Preclinical
ASD-004
Breast Cancer
Asdera LLC
0
catalysts
Phase 1
ASD-141
Solid Tumor
Ascendo Biotechnology Inc
0
catalysts
Phase 1
AST-021p
Epithelial Ovarian Cancer
Aston Sci Inc
0
catalysts
Phase 1
AST-201
Ovarian Cancer
EpiThany Inc
0
catalysts
Phase 1
AT-0365
Breast Cancer
Axcynsis Therapeutics Pte Ltd
0
catalysts
Preclinical
AT-211
Adenocarcinoma Of The Gastroesophageal Junction
AbTis Co Ltd
0
catalysts
Phase 1
ATA-2271
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
0
catalysts
Preclinical
ATG-012
Solid Tumor
Antengene Corp Ltd
0
catalysts
Phase 1
ATG-031
B-Cell Non-Hodgkin Lymphoma
Antengene Corp Ltd
0
catalysts
Phase 2
ATRN-119
Ovarian Cancer
$APRE
Aprea Therapeutics, Inc.
0
catalysts
Preclinical
ATX-101
T-Cell Lymphomas
Abcon Therapeutics Inc
0
catalysts
Phase 2
ATX-295
Ovarian Cancer
Accent Therapeutics Inc
0
catalysts
Phase 1
AU-409
Bile Duct Cancer (Cholangiocarcinoma)
Auransa Inc
0
catalysts
Preclinical
AUM-302
Neuroblastoma
AUM Biosciences Pte Ltd
0
catalysts
Phase 2
AUTO-3
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
$AUTL
Autolus Therapeutics plc
0
catalysts
Phase 1
AUTX-703
Myelodysplastic Syndrome (Preleukemia)
Auron Therapeutics Inc
0
catalysts
Phase 1
AV-203
Bladder Cancer
Receptor tyrosine-protein kinase erbB-3
AVEO Pharmaceuticals Inc
0
catalysts
